Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder. (Q37277682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

main subject

phase II clinical trial

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

David I Quinn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Niklas J Mackler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Rodney L Dunn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Maha Hussain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

David Wood

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Cheryl T Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Martin Sanda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ulka Vaishampayan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Daniel P Petrylak

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kathleen Beekman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

James E Montie

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

18 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

2384-8; discussion 2388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

24 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Optimal two-stage designs for phase II clinical trials

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716704

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18930256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18930256

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JURO.2008.08.075

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18930256%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

18930256

1 reference